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A 49-year-old man was admitted to hospital 
complaining of intractable abdominal pain accom-
panied by bouts of diarrhea, flushing, and weight 
loss. Patient history indicated neuroendocrine 
pancreatic tumor (pNET) infiltrating Vater’s pa-
pilla, duodenum and peripancreatic lymph nodes 
sealed by radical Whipple’s operation. The inoper-
able multifocal relapse in the abdomen and pelvis 
Figure 1. A. Radiotracer accumulated in the cardiac apex (green arrow). Cardiac apex in computed tomography and 
echocardiography with no pathological structures (B, inset). Surgical excision of the tumor (C, D); LV — left ventricle; 
RV — right ventricle; RDP — right posterior descendent; OM — obtuse marginal.
clinical cardiology
Cardiology Journal 
2017, Vol. 24, No. 1, 94–95
DOI: 10.5603/CJ.2017.0011
Copyright © 2017 Via Medica
ISSN 1897–5593
94 www.cardiologyjournal.org
IMAGE IN CARDIOVASCULAR MEDICINE
was treated with 6 cycles of systemic chemo-
therapy, subsequent radical surgical excision of 
the residual masses and 9-month treatment with 
somatostatin analog. A scintigraphy performed 
3 months prior to admission revealed a lesion lo-
cated in close proximity to the superior mesenteric 
artery. The recurrent tumor was excised, but due 
to positive surgical margins, adjuvant radiotherapy 
was administered. Subsequent positron emission 
tomography (PET)/computed tomography (CT) 
performed at admission documented recurrent 
lesion close to mesenteric artery together with 
an intensive accumulation of the radiotracer in the 
cardiac apex (Fig. 1A) not apparent in CT (Fig. 1B) 
and echocardiography (Fig. 1B, inset). Due to 
highly improved performance status of the patient 
reporting only grade 1 diarrhea, cardiosurgical exci-
sion of a 5 cm tumor was successfully performed 
(Fig. 1C, D) and sealed by a sandwich Dacron patch 
(Fig. 1E). Due to expected progression of other in-
operable abdominal metastatic lesions, the patient 
was offered everolimus given orally at daily doses 
of 10 mg, and proceeded with no evidence of intol-
erance. The postoperative course was uneventful, 
and the patient was discharged on the 6th day post 
intervention.
Cardiac metastases from pNET belong to ex-
tremely unusual presentations of cancer progres-
sion. Cardiovascular symptoms are usually masked 
by other more prominent adverse events of ad-
vanced cancer. Up to 20% of cases may develop car-
cinoid heart disease with right-sided valve lesions or 
heart failure. So far, little is known about the clinical 
impact of cardiac metastasis on overall survival.
Herein was presented a unique case of a car-
diac apex metastasis detectable only on 18-FDG 
PET/CT, which was treated successfully with 
radical surgical excision.
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